Objective To elucidate the clinical value of dynamic blood pressure monitor in the diagnosis and treatment of hypertensive heart diseases. Methods Twelve misdiagnosed patients with congestive heart failure were enrolled, including 7 male and 5 female, aging 67 to 78 years old. The hospitalization time, frequency and the therapeutic efficiency were compared before and after the diagnosis with the aid of dynamic blood pressure monitor. Results With the aid of dynamic blood pressure monitor, the patients with congestive heart failure were easily diagnosed. Following the proper control of high blood pressure, the heart failure improved swiftly. The hospitalization time was shorter and the hospitalization frequency was reduced as compared with that before proper diagnosis. Conclusion Dynamic blood pressure monitor is conducive to the diagnosis and treatment of congestive heart failure.

To investigate the protection effect of trimetazidine on patients with diabetic cardiomyopathy.Collection in January 2005～2008 in my years in October inpatient and outpatient services and long-term use of trimetazidine in patients with diabetic cardiomyopathy a total of 121 cases,divided by age:A group (the control group,59 people),B group ( treatment group,62 people),both groups with conventional medical treatment before and after treatment measured in fasting blood glucose,OGTT after 2 h blood glucose,blood lipids (total cholesterol,triglycerides),prothrombin time (PT),KPTT activation time (APTT),electrocardiogram QT dispersion,high-sensitivity C-reactive protein,blood pressure,ejection fraction (EF),left ventricular fractional shortening (FS),and compared before and after treatment LVMI (left ventricular mass index) and RWT (relative Room wall thickness).The results compared with those before treatment,B group significantly improved clinical symptoms,EF and FS compared to no significant difference,lowering blood lipids,blood glucose decreased,compared with A group,B group electrocardiogram QT dispersion has improved,B group LVMI,RWT ,high-sensitivity C-reactive protein lower than the A group (P<0.05);conclusions trimetazidine supplement the treatment of diabetic cardiomyopathy.

Objective To detect the serum level of C-reactive protein in the hypertension patients and analyze its relationship with the heart function impairment. Methods The hypertension patients who had no, or mild, or severe heart function impairment were selected and accordingly divided into 3 groups (n=26 in each group). Meanwhile another 26 healthy subjects served as normal controls. The heart function of all subjects were evaluated and scored according to heart function classified schedule published by New York Heart Disease Association (1928) and CRP levels were measured by scatter turbidimetry within 24 h after diagnosis. Results The scores of heart function for healthy patients and the hypertension patients without heart function impairment were within the normal range and their serum CRP levels were at the basic level. The scores and the serum CRP levels of the hypertension patients with mild heart function impairment were higher than that of healthy subjects and the hypertension patients without heart function impairment (P

Objective:To observe the changes of nutrition impact symptoms (NIS) and fat-free mass and analyze the relationship between them in patients with head and neck cancer (HNC) during radiotherapy.Methods:A convenient sampling method was adopted to select HNC patients who received radiotherapy in the outpatient clinic of department of radiotherapy for head and neck cancer in a cancer hospital in Beijing from March 2017 to January 2020. The nutrition impact symptoms (NIS) were assessed by a nutrition impact symptoms checklist and the fat free mass was assessed by bioelectrical impedance analysis at three time points: before radiotherapy (T1), during radiotherapy (T2) and at the end of radiotherapy (T3). The Generalized Estimating Equations (GEE) was used to analyze the relationship between them.Results:A total of 542 HNC patients were included in the analysis. During radiotherapy, the patients' NIS number and score presented an increasing trend, reaching the highest level and peaked at the end of radiotherapy. The change of fat-free mass showed a decreasing trend and reached the minimum at the end of radiotherapy. Patients with higher NIS scores had more percentage loss of fat-free mass.Conclusions:During radiotherapy, patients with HNC showed an increase in NIS score and lost fat-free mass. Patients with higher NIS score lost more percentage of fat-free mass, which suggested that clinical medical staff should pay attention to NIS management and take comprehensive intervention measures in time to reduce the loss of fat-free mass.